In a report released yesterday, Geulah Livshits from Chardan Capital maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research ...

For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...

TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...

Truist raised the firm’s price target on Crispr Therapeutics (CRSP) to $120 from $100 and keeps a Buy rating on the shares. The company’s Q4 ...

The chip maker is likely to be watching OpenAI after a consortium headed by Elon Musk offered almost $100 billion for the ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...

ABC News’ Alexis Christoforous reports on what Fed Chair Jerome Powell is telling lawmakers about a “strong overall” economy.

AI agents, power struggles, and more apps from third-party developers: Here’s what’s coming in 2025 and beyond What will ...

BUENOS AIRES - Argentina's award-winning mare Polo Pureza will have her genes, or at least most of them, live on in five ...

A Canadian startup called Xanadu has built a photon-based quantum computer it says should easily scale up. What will really matter in the long run? That’s the question we tackle each year as we ...

Kevin Johnston is the owner of Corporate Writing Assignments. He has 12+ years of experience writing about several financial topics. Suzanne is a content marketer, writer, and fact-checker. She ...